Limits...
The public health impact of coccidioidomycosis in Arizona and California.

Hector RF, Rutherford GW, Tsang CA, Erhart LM, McCotter O, Anderson SM, Komatsu K, Tabnak F, Vugia DJ, Yang Y, Galgiani JN - Int J Environ Res Public Health (2011)

Bottom Line: The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively.Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups.Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine.

View Article: PubMed Central - PubMed

Affiliation: Global Health Sciences, University of California, San Francisco,1200 Beale St, #1200, San Francisco, CA 94105, USA. rhector@psg.ucsf.edu

ABSTRACT
The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively. Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups. Lack of early diagnosis continues to be a problem, particularly in suspect community-acquired pneumonia, underscoring the need for more rapid and sensitive tests. Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine.

Show MeSH

Related in: MedlinePlus

Coccidioidomycosis incidence and first hospitalization rates and percent hospitalization in California, 2001–2008.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC3118883&req=5

f8-ijerph-08-01150: Coccidioidomycosis incidence and first hospitalization rates and percent hospitalization in California, 2001–2008.

Mentions: Figure 8 presents coccidioidomycosis incidence and first hospitalization rates per 100,000 population as well as percent hospitalization in California. Reported cases and hospitalization rates followed similar trends over time. The percent hospitalization (hospitalization rate by reported incidence rate) decreased in 2003, followed by a plateau from 2003 to 2007, and increased in 2008.


The public health impact of coccidioidomycosis in Arizona and California.

Hector RF, Rutherford GW, Tsang CA, Erhart LM, McCotter O, Anderson SM, Komatsu K, Tabnak F, Vugia DJ, Yang Y, Galgiani JN - Int J Environ Res Public Health (2011)

Coccidioidomycosis incidence and first hospitalization rates and percent hospitalization in California, 2001–2008.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC3118883&req=5

f8-ijerph-08-01150: Coccidioidomycosis incidence and first hospitalization rates and percent hospitalization in California, 2001–2008.
Mentions: Figure 8 presents coccidioidomycosis incidence and first hospitalization rates per 100,000 population as well as percent hospitalization in California. Reported cases and hospitalization rates followed similar trends over time. The percent hospitalization (hospitalization rate by reported incidence rate) decreased in 2003, followed by a plateau from 2003 to 2007, and increased in 2008.

Bottom Line: The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively.Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups.Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine.

View Article: PubMed Central - PubMed

Affiliation: Global Health Sciences, University of California, San Francisco,1200 Beale St, #1200, San Francisco, CA 94105, USA. rhector@psg.ucsf.edu

ABSTRACT
The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively. Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups. Lack of early diagnosis continues to be a problem, particularly in suspect community-acquired pneumonia, underscoring the need for more rapid and sensitive tests. Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine.

Show MeSH
Related in: MedlinePlus